Gilead acquires XinThera to strengthen pipeline in oncology
Acquisition of XinThera provides Gilead with precision small molecules focused on PARP1 and MK2 Inhibitors
Acquisition of XinThera provides Gilead with precision small molecules focused on PARP1 and MK2 Inhibitors
The strategic appointment is also critical to reinforcing Healthium’s market leadership, corporate governance and deep domain expertis
Franson will help biopharma clients design a phased approach to inform and execute clinical development plans
The data from this study show that MM-II has the potential to provide durable pain relief for our patients
Digital success is contingent on the way a company organizes itself around technology
Ghostine has served as CEO of Geneva-based Firmenich, the world's largest privately owned perfume and taste company, since 2014.
The Applied Biosystems TaqPath PCR kits have been analytically- and clinically-validated for use in patient care
The agreement between Eli Lilly and Janssen was established to allow the two companies to share resources for the goal of accelerating the evaluation of the respective companies’ assets, mirikizumab and Tremfya (guselkumab).
Connectivity and harmonisation were both key driving factors behind our decision to choose the CARA Life Sciences Platform to consolidate our processes
Subscribe To Our Newsletter & Stay Updated